谷歌浏览器插件
订阅小程序
在清言上使用

YL202/BNT326, a HER3-targeted ADC, in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Breast Cancer: Preliminary Results from a First-in-human Phase I Trial.

Ying Cheng, Xiaochen Zhang,Jian Liu,Zhangzhou Huang, Dongqing Lv,Yiping Zhang,Xiaojia Wang,Arvind Chaudhry,Harshad Amin, Senthil Damodaran, Shiven B. Patel, Hadeel Assad,Arielle Shebay Lee, Hui Zhao, Jinyun Bai, Tongtong Xue, Steve Chin

Journal of Clinical Oncology(2024)

引用 0|浏览3
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要